JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.26, no.6, pp.242-247, 2020 (SCI-Expanded)
Article / Article
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
TNF-related apoptosis-inducing ligand receptor 1, TNF-alpha, ankylosing spondylitis, INCREASED EXPRESSION, TRAIL, CYTOKINES, THERAPY
Kocaeli University Affiliated:
Objectives: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor (TNF) superfamily and is reported to play a role in autoimmune diseases. In this study, we aimed to measure serum TRAIL receptor 1 (TRAIL-R1) concentration and assess any phenotypic relationship in patients with ankylosing spondylitis (AS).